The Board has determined that the Veteran's service-connected herpes simplex II virus requires constant or near-constant use of oral systemic anti-viral immunosuppressive drug therapy, warranting a 60 percent disability rating.
The deciding factor: The Veteran's herpes simplex II virus required daily anti-viral suppressive medication despite persistent outbreaks and symptoms, meeting the criteria for a 60 percent rating under Diagnostic Code 7820-7816.
- Claimed conditions
- Herpes Simplex II
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- February 11, 2016
- Citation
- 1605394
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Search VA.gov for the original decision (opens in a new tab) using citation 1605394.
What this means for you
A grant means the Board allowed the benefit or issue identified in this decision. Review the original order: other issues in the same appeal may have a different outcome, and this decision does not predict another claim.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Denied
The Veteran's herpes simplex II was rated as noncompensable, and the Board denied an initial compensable rating due to the condition affecting less than 5 percent of his entire body and exposed areas.
- Whole decision: Denied
The Veteran's herpes simplex II affected less than 20 percent of his body and exposed areas, and did not require systemic therapy for more than six weeks over a 12-month period. Therefore, the claim for an increased disability rating is denied.
- Whole decision: Denied
The Board denied service connection for Herpes Simplex II and Obstructive Sleep Apnea. The claim for Herpes Simplex II was denied as there is no evidence of a current diagnosed medical condition during or after service, while the claim for Obstructive Sleep Apnea was remanded due to conflicting opinions on its etiology.
- Whole decision: Dismissed
The Board dismissed the Veteran's appeals for increased disability rating for service-connected Herpes Simplex II, earlier effective date for service connection for depressive disorder and tender scarring related to pilonidal cyst removal. The issues were withdrawn by the Veteran.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.